BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chow AKM, Yau SWL, Ng L. Novel molecular targets in hepatocellular carcinoma. World J Clin Oncol 2020; 11(8): 589-605 [PMID: 32879846 DOI: 10.5306/wjco.v11.i8.589]
URL: https://www.wjgnet.com/1948-5182/full/v11/i8/589.htm
Number Citing Articles
1
Sidra Altaf, Faiza Saleem, Azam Ali Sher, Ashiq Ali. Potential Therapeutic Strategies to Combat HCCCurrent Molecular Pharmacology 2022; 15(7): 929 doi: 10.2174/1874467215666220103111009
2
Yu Wang, Baocheng Deng. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkersCancer and Metastasis Reviews 2023; 42(3): 629 doi: 10.1007/s10555-023-10084-4
3
Yanli Wang, Xiaoqing Zhu, Kailiang Wang, Ying Cai, Chunhua Liu, Jie Pan, Jia Sun, Ting Liu, Yong Huang, Yongjun Li, Yuan Lu. Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicinBiomedical Chromatography 2022; 36(10) doi: 10.1002/bmc.5451
4
Tingting Li, Tong Li, Zhiqiang Wang, Yingxue Jin. Cyclopeptide-based Anti-liver Cancer Agents: A Mini-reviewProtein & Peptide Letters 2023; 30(3): 201 doi: 10.2174/0929866530666230217160717
5
Fernanda Villarruel-Melquiades, María Eugenia Mendoza-Garrido, Claudia M García-Cuellar, Yesennia Sánchez-Pérez, Julio Isael Pérez-Carreón, Javier Camacho. Current and novel approaches in the pharmacological treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(17): 2571-2599 doi: 10.3748/wjg.v29.i17.2571
6
Patrizia Cioni, Edi Gabellieri, Barbara Campanini, Stefano Bettati, Samanta Raboni. Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential ApplicationsCurrent Medicinal Chemistry 2022; 29(3): 411 doi: 10.2174/0929867328666210713094722
7
Junxiao Wang, Rui Liu, Yun Zhao, Zhenhu Ma, Zejie Sang, Zhenyu Wen, Xueling Yang, Hui Xie. Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation ImagingFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.743055
8
Nouf Juaid, Amr Amin, Ali Abdalla, Kevin Reese, Zaenah Alamri, Mohamed Moulay, Suzan Abdu, Nabil Miled. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets InsightsInternational Journal of Molecular Sciences 2021; 22(19): 10774 doi: 10.3390/ijms221910774
9
Smriti Verma, Bidya Dhar Sahu, Madhav Nilakanth Mugale. Role of lncRNAs in hepatocellular carcinomaLife Sciences 2023; 325: 121751 doi: 10.1016/j.lfs.2023.121751
10
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher, Niels Olsen Saraiva Câmara, Mathieu Vinken, Bruno Cogliati. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational ModelingCancers 2021; 13(21): 5583 doi: 10.3390/cancers13215583
11
Chang Xu, Xudong Gao, Tianshu Ren, Hefeng Geng, Kaisi Yang, Yaoguang Huang, Weige Zhang, Shanbo Hou, Aigang Song, Yingshi Zhang, Qingchun Zhao. The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talkPharmacological Research 2024; 203: 107142 doi: 10.1016/j.phrs.2024.107142
12
Noriko Yamada, Rie Matsushima-Nishiwaki, Kaido Kobayashi, Junko Tachi, Osamu Kozawa. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathwayArchives of Biochemistry and Biophysics 2021; 703: 108851 doi: 10.1016/j.abb.2021.108851
13
Jing-Yi Mou, Zhang-Wen Ma, Meng-Ying Zhang, Quan Yuan, Zi-Yi Wang, Qing-Hua Liu, Fen Li, Zhao Liu, Liang Wang. Structural abnormality of hepatic glycogen in rat liver with diethylnitrosamine-induced carcinogenic injuryInternational Journal of Biological Macromolecules 2024; 260: 129432 doi: 10.1016/j.ijbiomac.2024.129432